MOREPENLAB.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 06, 2026

Report Source: 2026 3rd Quarter Report

Morepen Laboratories Ltd

Morepen Laboratories Ltd. Stock Analysis MOREPENLAB.NS

India Health Care Micro Cap Report:
Morepen Laboratories Ltd. engages in the provision of business of manufacturing bulk drugs, intermediates, and medical devices; and business of formulation. The company is headquartered in Gurgaon, Haryana and currently employs 1,814 full-time employees. The firm is in the business of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also home health products. Its APIs include Apixaban, Edoxaban, Linagliptin, Linagliptin + Metformin, Empagliflozin, Empagliflozin + Metformin, Atorvastatin, Rosuvastain, Rivaroxaban, Febuxostat, Montelukast (Oral), Montelukast (Chewable), Montelukast Sodium, among others. Its finished formulations include Intebact Capsules, Intelicaps Lax, Rythmix Kid Drop, Rythmix Kid Syrup, Kompact Powder, Saltum and Acifix 3X Suspension among others. Its home health products include Dr. Morepen 49W Room Air Purifier with HEPA Filter, Dr. Morepen VP06 Breathe Free Vaporizer, Dr. Morepen CN06 Compressor Nebulizer and Dr. Morepen ST03 Dual Head Stethoscope, among others. Its subsidiaries include Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited.
Read More

Morepen Laboratories Ltd (MOREPENLAB.NS) Chart

Key Statistics of Morepen Laboratories Ltd (MOREPENLAB.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹41.82₹42.99

Today's Open

₹42.70

Volume

2.01M

P/E Ratio (TTM)

19.92

52 Week Range

₹33.05₹70.50

Market Cap

22.98B

Avg. Volume

3.80M

Dividend Yield

-

Financial Metrics & Statements of Morepen Laboratories Ltd (MOREPENLAB.NS)

FAQ's for Morepen Laboratories Ltd (MOREPENLAB.NS)

  • According to Musaffa’s Shariah screening methodology, Morepen Laboratories Ltd (MOREPENLAB.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.